Previous close | 21.98 |
Open | 21.98 |
Bid | 21.71 x 800 |
Ask | 21.82 x 1200 |
Day's range | 21.56 - 21.98 |
52-week range | 18.15 - 27.35 |
Volume | |
Avg. volume | 113,300 |
Market cap | N/A |
Beta (5Y monthly) | 1.57 |
PE ratio (TTM) | 2.94 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.41 (6.35%) |
Ex-dividend date | 29 Jul 2022 |
1y target est | N/A |
NEW YORK, July 07, 2022--Prove Identity, Inc. ("Prove"), the leader in digital identity, today announced it has facilitated 25 million "radically simple" customer credit card applications with Synchrony (NYSE: SYF), a premier consumer financial services company. Synchrony leverages Prove’s Pre-Fill and Identity solutions to dramatically simplify its customer application and account opening processes by reducing the number of fields a customer must complete by 80% compared to previous application
BRISBANE, Calif. & STAMFORD, Conn., April 20, 2022--CUTERA, INC. (Nasdaq: CUTR), a leading provider of dermatological solutions, and Synchrony (NYSE: SYF), a leading provider of consumer payment and financing solutions, today announce an exclusive partnership to expand patient financing options to dermatology practices across the United States. Cutera’s AviClear is the first and only device cleared by the FDA for the treatment of mild, moderate and severe acne. Dermatologists offering AviClear w
DEERFIELD, Ill. & STAMFORD, Conn., August 16, 2021--Walgreens (Nasdaq: WBA) today introduced the new myWalgreens Credit Card program, featuring two industry-first retail health and wellness credit cards, issued by Synchrony Bank (NYSE: SYF). The myWalgreens Mastercard and the myWalgreens Credit Card are the first ever of their kind to reward more personalized wellbeing choices and offer industry-leading rewards at more than 9,000 Walgreens locations, Walgreens.com, Duane Reade stores, via the Wa